Our First Year Anniversary PDF Print E-mail
Wednesday, 14 October 2009 22:22
taken from http://www.flickr.com/photos/funkybug/2795601840/ via creative commonsCelebrating an important anniversary is always a blessing. The Scleroderma Care Foundation was officially incorporated on 15th October 2008. Its mission to provide support and education for persons afflicted with Scleroderma within Trinidad and Tobago became a reality after months of thought, deliberation and legal preparation. Working alongside my son Adelwyn Holder, I anticipated an organization that would be welcomed and appreciated by many persons who were suffering alone because of the devastating effects Scleroderma.

Our first year has been magnificent. The Lord has been placing the right persons in our path to achieve our vision for our members. Although the Foundation was incorporated in October 2008, the initial months were nothing short of challenging, as the ground work took time. The loss of my friend Jennifer Hannibal, who succumbed to Scleroderma in January 2009, and news of two other Scleroderma related deaths propelled my desire to ‘get the ball rolling’. The Support Group met for the first time on Sunday 15th February, 2009. Five persons and their families and close friends spent time together. There were tears of joy and tears of sorrow that evening… but we were all just grateful that we no longer had to deal with this condition alone. Thank God!

The future of the Scleroderma Care Foundation is indeed ladened with hope and extreme promise. I hope that all Scleroderma sufferers in Trinidad and Tobago, and by extension, the world, would realize the importance of accepting support when trying to fight such diseases, like Scleroderma. I hope that the general public and the health-challenged would realize that quality of life is closely related to healthier life-styles. My greater hope is for all to be educated regarding the difficulties and life-altering effects of Scleroderma on a persons’ life, causing better understanding, appreciation and interaction with such persons.

Today, as we celebrate our first anniversary I pray for the Lord’s continued blessing for the Scleroderma Care Foundation, its members, family, friends and supporters. God Bless you richly with an abundance of good health!

Susan Le Gendre
Co-Founder and Vice-President
 
More articles :

» Potential Therapy for Scleroderma Lung Disease Uncovered

Investigators, partially supported by the , have found that a deficiency in the protein caveolin-1 (cav-1) is linked to the development of, the scarring of lung tissue that causes disability and death in people with . The scientists, from the...

» Glucosamine, Chondroitin and MSM as Alternative Therapies for Scleroderma

In an article titled, "Glucosamine, Chondroitin and MSM as Alternative Therapies for Scleroderma", Dr. Robert B. Buckingham, M.D., discussed three alternative medicines for treating the pain and the other features associated with . Here, we sought...

» Study Suggests Link Between Scleroderma, Cancer in Certain Patients

Patients with a certain type of may get cancer and scleroderma simultaneously, Johns Hopkins researchers have found, suggesting that in some diseases, autoimmunity and cancer may be linked.These findings could lead researchers closer to discovering...

» PDE-5 Inhibitors in Scleroderma Raynaud Phenomenon and Digital Ulcers: Current Status of Clinical Trials

Ann J. Impens, Kristine Phillips, and Elena SchiopuReceived 2 June 2011; Accepted 2 August 2011Phosphodiesterases (PDEs) are isoenzymes that control the level of intracellular cyclic guanosine monophosphate (cGMP) and cyclic adenosine monophosphate...

» Quality Indicator Sets For Scleroderma

Despite the increasing awareness of Scleroderma (SSc), it continues to have a detrimental effect of the quality of health and lives of those with it. The medical community has recognized that although early treatment of can have a substantial...

» Pulsed High-Dose Corticosteroids Combined With Low-Dose Methotrexate in Severe Localized Scleroderma

Alexander Kreuter, MD; Thilo Gambichler, MD; Frank Breuckmann, MD; Sebastian Rotterdam, MD; Marcus Freitag, MD; Markus Stuecker, MD; Klaus Hoffmann, MD; Peter Altmeyer, MDArch Dermatol. 2005;141:847-852Objective: To evaluate the efficacy of pulsed...

Comments  

 
0 #1 adelwyn 2009-10-16 20:00
It has indeed been a pleasure working with the Foundation. I do look forward to another year of great work, and pray that we can deliver much greater benefit to Scleroderma patients locally.
Report to administrator